Fundraising

Ollin Biosciences

Ollin Biosciences Raises $100M in Series A

2022
Founded
70+
Employees
Austin, TX
2 min read

Quick Facts

Ollin Biosciences Raises $100M in Series A


Ollin Biosciences has successfully raised $100M in a Series A at a $500M valuation led by Deerfield Management, ARCH Venture Partners.


Company Overview


Ollin Biosciences is a Biotech company headquartered in Austin, TX, founded in 2022 with 70+ employees.


Clinical-stage company for vision-threatening disease therapies


Fundraising Details


  • Amount Raised: $100M
  • Round Type: Series A
  • Valuation: $500M
  • Date: 2025-09-25
  • Investors: Deerfield Management, ARCH Venture Partners

About Ollin Biosciences


Clinical-stage company for vision-threatening disease therapies The company is positioned in the Biotech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Austin, TX
  • Founded: 2022
  • Team Size: 70+
  • Industry: Biotech

What This Means


This funding round demonstrates strong investor confidence in Ollin Biosciences's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Ollin Biosciences's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $500M valuation marks an important milestone for Ollin Biosciences, positioning the company among notable players in the Biotech industry.


Looking Ahead


With this new capital, Ollin Biosciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-09-25. For more information about Ollin Biosciences, visit their headquarters at Austin, TX.

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news